News

Hexoskin @ 2024 JP Morgan Conference

Hexoskin will be in San Francisco again this year during the 42nd Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.

We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.

We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.

Contact us to book a meeting: contact@hexoskin.com

HITLAB Digital Health Summit 2023 - Hexoskin Video

Our CEO Pierre-Alexandre Fournier presented some of Hexoskin's efforts to solve the evidence gap for healthcare and clinical trials at Columbia University last month, and HITLAB recently made the 15 minutes video available online below.

Clinical evidence is what makes medical discoveries possible: that's how we measure safety and efficacy, and that's how we measure efficiency gains in healthcare delivery. When we lower the cost of evidence, we make care more accessible and affordable. This is an important part of our mission at Hexoskin.

In the video you'll see a few examples of our work at Hexoskin, from clinical research to AI development to human spaceflight.

The Hexoskin and Astroskin platform has been used to collect health data for over 200 scientific publications. White papers about wearable sensors applications for health monitoring of are available upon request.

Hexoskin Presenting at the Emerging Medtech Summit

Hexoskin - LSI - Emerging Medtech Summit 2022 - Pierre-Alexandre Fournier - CEO

Pierre-Alexandre Fournier, CEO of Hexoskin was selected as an Innovation Leader for the #LSIUSA22 Emerging Medtech Summit. Hexoskin's CEO will present at the event on March 15-18, 2022, and announce exciting new products and partnerships aimed to help patients have better access to healthcare.

Pierre-Alexandre has been involved in health sensor development and artificial intelligence projects for over 15 years and advises many public and private organizations on these topics in the US, Canada and Europe. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.

Hexoskin Smart Garments utilize embedded textile sensors to continuously monitor vital signs. Hexoskin smart clothing is capable of monitoring cardiac, pulmonary, activity, and sleep digital biomarkers.

The Emerging Medtech Summit will feature 150 vetted presenting companies, panel sessions, 1:1 meetings, and networking opportunities.

Hexoskin Selected for the Inaugural Mayo Clinic and ASU MedTech Accelerator

Our team is excited to announce that Hexoskin is one of only six medical technology companies selected by the Mayo Clinic and Arizona State University (ASU) for its inaugural MedTech Accelerator cohort. The accelerator, which is part of the Mayo Clinic Arizona State University Alliance for Health Care, was designed specifically for medical device and health care technology companies looking to partner with Mayo Clinic and ASU.

"The inaugural cohort of the program consists of six extremely dynamic startups with product offerings we feel are poised to improve patient care and outcomes through their new innovations," says Steven Lester, M.D., a Mayo Clinic cardiologist and medical director of the accelerator. Dr. Lester, professor of Medicine, is also associate medical director of Mayo Clinic's Department of Business Development.

"At Hexoskin we see a great fit between our vision for at-home patient monitoring, post-acute care, and chronic disease management and Mayo Clinic's mission to put the best interest of the patient first." says Pierre-Alexandre Fournier, MScA, Co-founder and CEO of Hexoskin.

Hexoskin provides a seamless integration of its smart shirts for vital signs monitoring with hospitals’ existing processes to improve upon the patient experience. The accelerator program gives Hexoskin the opportunity to collaborate with the country’s most distinguished medical mentors and researchers and develop new clinical opportunities for Hexoskin technology. 


About Hexoskin

Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Sourcehttps://newsnetwork.mayoclinic.org/discussion/mayo-clinic-asu-select-six-startups-for-inaugural-medtech-accelerator-cohort/